Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4282957
Max Phase: Preclinical
Molecular Formula: C18H24Cl2N4
Molecular Weight: 367.32
Molecule Type: Small molecule
Associated Items:
ID: ALA4282957
Max Phase: Preclinical
Molecular Formula: C18H24Cl2N4
Molecular Weight: 367.32
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: N=C(CCl)NCCCc1nn(CC2CCCC2)c2c(Cl)cccc12
Standard InChI: InChI=1S/C18H24Cl2N4/c19-11-17(21)22-10-4-9-16-14-7-3-8-15(20)18(14)24(23-16)12-13-5-1-2-6-13/h3,7-8,13H,1-2,4-6,9-12H2,(H2,21,22)
Standard InChI Key: GMCBPYFYWNHASP-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 367.32 | Molecular Weight (Monoisotopic): 366.1378 | AlogP: 4.62 | #Rotatable Bonds: 7 |
Polar Surface Area: 53.70 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.95 | CX LogP: 3.91 | CX LogD: 1.73 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.32 | Np Likeness Score: -0.98 |
1. Tjin CC, Wissner RF, Jamali H, Schepartz A, Ellman JA.. (2018) Synthesis and Biological Evaluation of an Indazole-Based Selective Protein Arginine Deiminase 4 (PAD4) Inhibitor., 9 (10): [PMID:30344909] [10.1021/acsmedchemlett.8b00283] |
Source(1):